JP6827962B2 - 過剰体重に影響される女性患者のためのドロスピレノン系避妊薬 - Google Patents

過剰体重に影響される女性患者のためのドロスピレノン系避妊薬 Download PDF

Info

Publication number
JP6827962B2
JP6827962B2 JP2017567465A JP2017567465A JP6827962B2 JP 6827962 B2 JP6827962 B2 JP 6827962B2 JP 2017567465 A JP2017567465 A JP 2017567465A JP 2017567465 A JP2017567465 A JP 2017567465A JP 6827962 B2 JP6827962 B2 JP 6827962B2
Authority
JP
Japan
Prior art keywords
contraceptive
drsp
women
drospirenone
daily
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017567465A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018527305A5 (enExample
JP2018527305A (ja
Inventor
ドゥロィン，ドミニク
ボイヤー−ジュベール，セシル
ペラン，フィリップ
Original Assignee
ラボラトリオス レオン ファーマ エスエー
ラボラトリオス レオン ファーマ エスエー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56178376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP6827962(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP15305965.4A external-priority patent/EP3108889A1/en
Priority claimed from CN201510348953.1A external-priority patent/CN106265694A/zh
Application filed by ラボラトリオス レオン ファーマ エスエー, ラボラトリオス レオン ファーマ エスエー filed Critical ラボラトリオス レオン ファーマ エスエー
Publication of JP2018527305A publication Critical patent/JP2018527305A/ja
Publication of JP2018527305A5 publication Critical patent/JP2018527305A5/ja
Application granted granted Critical
Publication of JP6827962B2 publication Critical patent/JP6827962B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2017567465A 2015-06-23 2016-06-23 過剰体重に影響される女性患者のためのドロスピレノン系避妊薬 Active JP6827962B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201510348953.1 2015-06-23
EP15305965.4 2015-06-23
EP15305965.4A EP3108889A1 (en) 2015-06-23 2015-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight
CN201510348953.1A CN106265694A (zh) 2015-06-23 2015-06-23 用于过重女性患者的基于屈螺酮的避孕药
PCT/EP2016/064574 WO2016207298A1 (en) 2015-06-23 2016-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight

Publications (3)

Publication Number Publication Date
JP2018527305A JP2018527305A (ja) 2018-09-20
JP2018527305A5 JP2018527305A5 (enExample) 2019-07-18
JP6827962B2 true JP6827962B2 (ja) 2021-02-10

Family

ID=56178376

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017567465A Active JP6827962B2 (ja) 2015-06-23 2016-06-23 過剰体重に影響される女性患者のためのドロスピレノン系避妊薬

Country Status (26)

Country Link
EP (1) EP3313408B1 (enExample)
JP (1) JP6827962B2 (enExample)
KR (1) KR102217942B1 (enExample)
CN (2) CN113750108B (enExample)
AU (1) AU2016282863B2 (enExample)
BR (1) BR112017028048A2 (enExample)
CA (1) CA2989975C (enExample)
DK (1) DK3313408T3 (enExample)
EA (1) EA036497B1 (enExample)
ES (1) ES2970532T3 (enExample)
FI (1) FI3313408T3 (enExample)
HR (1) HRP20240121T8 (enExample)
HU (1) HUE065350T2 (enExample)
LT (1) LT3313408T (enExample)
MX (1) MX389310B (enExample)
MY (1) MY187233A (enExample)
NI (1) NI201700173A (enExample)
PH (1) PH12017502379A1 (enExample)
PL (1) PL3313408T3 (enExample)
RS (1) RS65196B1 (enExample)
SI (1) SI3313408T1 (enExample)
SM (1) SMT202400062T1 (enExample)
SV (1) SV2017005602A (enExample)
UA (1) UA122873C2 (enExample)
WO (1) WO2016207298A1 (enExample)
ZA (1) ZA201800067B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
RS57328B1 (sr) 2015-06-18 2018-08-31 Mithra Pharmaceuticals S A Orodisperzibilna dozna jedinica koja sadrži estetrolsku komponentu
WO2016203044A1 (en) 2015-06-18 2016-12-22 Mithra Pharmaceuticals S.A. Orodispersible tablet containing estetrol
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
NZ737945A (en) 2015-06-18 2023-06-30 Estetra Sprl Orodispersible dosage unit containing an estetrol component
DK3313408T3 (da) 2015-06-23 2024-01-29 Laboratorios Leon Farma Sa Drospirenon-baseret svangerskabsforebyggende middel til en kvindelig patient, som lider af overvægt
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
CR20200486A (es) 2018-04-19 2021-01-27 Estetra Sprl Compuestos y sus usos para aliviar los síntomas asociados a la menopausa
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
EP4134082A1 (en) 2021-08-12 2023-02-15 Chemo Research, S.L. Method for treating endometriosis and providing effective contraception

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
AU2002368326A1 (en) * 2002-11-05 2004-06-07 Schering Aktiengesellschaft Hormone replacement therapy with drospirenone
CN107875388A (zh) * 2004-04-30 2018-04-06 拜耳知识产权有限责任公司 对延长的激素避孕方案中突破性出血的控制
MY151322A (en) * 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
US20060009428A1 (en) * 2004-07-07 2006-01-12 Wyeth Cyclic progestin regimens and kits
ITMI20042338A1 (it) 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
PT1746101E (pt) 2005-07-21 2008-10-27 Bayer Schering Pharma Ag Processo para o fabrico de 3-oxo-pregn-4-eno-21,17-carbolactonas por meio de oxidação isenta de metais de 17-(3-hidroxipropil)-3,17-di-hidroxiandrostanos
BRPI0810049A2 (pt) * 2007-04-05 2015-05-05 Bayer Schering Pharma Ag Regime de drospirenona/17beta-estradiol, produto de combinação farmacêutica e kit para realizar esse regime
EP2548881B1 (en) * 2010-03-16 2014-12-17 Taizhou Taifa Pharmaceuticals Co., Ltd Preparation method of drospirenone
RU2422824C1 (ru) * 2010-05-07 2011-06-27 Федеральное Государственное Учреждение Ростовский научно-исследовательский институт акушерства и педиатрии Федерального агентства по высокотехнологичной медицинской помощи Способ выбора тактики лечения нарушений менструального цикла у девочек-подростков с избыточной массой тела
US9375437B2 (en) * 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
AR081670A1 (es) * 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
CN103372015A (zh) * 2012-04-19 2013-10-30 国家人口计生委科学技术研究所 包含屈螺酮或屈螺酮和雌激素的阴道环制剂
RU2527357C1 (ru) * 2013-08-02 2014-08-27 Государственное бюджетное образовательное Учреждение высшего профессионального образования "Московский государственный медико-стоматологический университет имени А.И. Евдокимова" Министерства здравоохранения Российской Федерации (МГМСУ имени А.И. Евдокимова" Минздрава России) Способ персонифицированной профилактики эстрогензависимых заболеваний у здоровых женщин и женщин с факторами сердечно-сосудистого риска в возрасте 45-60 лет
DK3313408T3 (da) 2015-06-23 2024-01-29 Laboratorios Leon Farma Sa Drospirenon-baseret svangerskabsforebyggende middel til en kvindelig patient, som lider af overvægt

Also Published As

Publication number Publication date
EA036497B1 (ru) 2020-11-17
HUE065350T2 (hu) 2024-05-28
UA122873C2 (uk) 2021-01-13
PL3313408T3 (pl) 2024-04-15
JP2018527305A (ja) 2018-09-20
LT3313408T (lt) 2024-03-12
CA2989975C (en) 2021-10-12
KR20180019173A (ko) 2018-02-23
HK1255216A1 (zh) 2019-08-09
AU2016282863A1 (en) 2018-02-08
SV2017005602A (es) 2018-08-14
SI3313408T1 (sl) 2024-04-30
CA2989975A1 (en) 2016-12-29
HRP20240121T8 (hr) 2024-05-10
NI201700173A (es) 2018-04-02
BR112017028048A2 (pt) 2018-09-04
AU2016282863B2 (en) 2021-05-27
CN113750108B (zh) 2025-08-19
SMT202400062T1 (it) 2024-03-13
CN108025014A (zh) 2018-05-11
MX2017016801A (es) 2018-05-11
ZA201800067B (en) 2019-07-31
HRP20240121T1 (hr) 2024-04-12
MX389310B (es) 2025-03-20
FI3313408T3 (fi) 2024-01-25
DK3313408T3 (da) 2024-01-29
ES2970532T3 (es) 2024-05-29
CN108025014B (zh) 2021-10-22
WO2016207298A1 (en) 2016-12-29
NZ739195A (en) 2024-04-26
CN113750108A (zh) 2021-12-07
KR102217942B1 (ko) 2021-02-19
EA201792595A1 (ru) 2018-06-29
MY187233A (en) 2021-09-13
EP3313408B1 (en) 2023-12-06
PH12017502379A1 (en) 2018-06-25
RS65196B1 (sr) 2024-03-29
EP3313408A1 (en) 2018-05-02

Similar Documents

Publication Publication Date Title
US11291633B2 (en) Synthetic progestogens and pharmaceutical compositions comprising the same
US12280151B2 (en) Synthetic progestogens and pharmaceutical compositions comprising the same
AU2016282863B2 (en) Drospirenone-based contraceptive for a female patient affected with excess weight
US10179140B2 (en) Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
EP3108889A1 (en) Drospirenone-based contraceptive for a female patient affected with excess weight
HK40061928A (en) Drospirenone-based contraceptive for a female patient affected with excess weight
HK40061928B (zh) 用於过重女性患者的基於屈螺酮的避孕药
CN106265694A (zh) 用于过重女性患者的基于屈螺酮的避孕药
HK1232778A1 (en) Drospirenone-based contraceptive for a female patient affected with excess weight
HK1232778A (en) Drospirenone-based contraceptive for a female patient affected with excess weight
OA18512A (en) Drospirenone-based contraceptive for a female patient affected with excess weight.
HK1255216B (zh) 用於过重女性患者的基於屈螺酮的避孕药
AU2011273605B8 (en) Pharmaceutical composition comprising drospirenone and contraceptive kit

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190612

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190612

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200527

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200619

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200917

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210106

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210120

R150 Certificate of patent or registration of utility model

Ref document number: 6827962

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250